Market News
Smart Trading. Simplified.
Jeff Bezos' Next Big Thing
The tech visionary who built a revolutionary $1.6 trillion company from scratch is quietly pouring his riches into a secretive project that could mean the end of Alzheimer's.
Early investors who get in by August 6th, 2021, could turn every $1,000 into $1.1 million.
What Stock To Buy When Interest Rates Rise?
What Stock To Buy When Interest Rates Rise? When it became clear that COVID-19 was spreading in the United States, local and state governments responded quickly. Stay-at-home orders went into effect, businesses were closed, and many economic activities came to a screeching halt. The sheer shock of those unprecedented moves sent the market into a […]
Small Biotech Could Soar 1,000%
There's no sector poised to deliver bigger gains in 2021 than small-cap biotech stocks.
In the past year alone...
Novavax Inc jumped from $6.26 to $270.51, a gain of 3,396%.
Aclaris Therapts jumped from $0.70 to $24.28 an increase of 1,583%.
Vaxart Inc rocketed from $0.97 to $14.94, a 1,083% jump.
Here's the next biotech we think could soar 1,000% >>>
Does Zebra Technologies Pay A Dividend?
Dividends serve as a reward for investors, almost like a thank you for having faith in and sticking with the company and helping to drive the company’s shares to new heights. They also tend to follow increases or decreases in the company’s price per share. With this in mind, does recent stock market superstar Zebra […]
The World's First $20 Trillion Drug?
One small biotech holds the key to a revolution in treating Alzheimer's. Jeff Bezos, Goldman Sachs & a Big Pharma giant have invested billions into this unknown biotech.
Our research shows that anyone who gets in by August 6th, 2021 could turn every $1,000 into $1.1 million.
AMC Entertainment Vs AMC Networks: What’s the Difference?
AMC Entertainment Holdings Inc (NYSE:AMC) made waves in 2021 by reaching a historic high market capitalization of $30 billion. The momentous skyrocket happened after a 3,325 percent boost from Reddit’s WallStreetBets subreddit community. Amid the furore, some traders mistakenly bought shares of AMC Networks Inc (NASDAQ:AMCX) while thinking they were buying AMC Entertainment stock. So, […]
New Investing eBook - Ultimate Guide to Real Estate Stocks.
Expand your portfolio by adding Real Estate Stocks and REITs that have outperformed the S&P 500 since the 1970s. Learn about these overlooked stocks and add high performance and stability to your portfolio.
How High Can Magnite Stock Go?
Magnite Inc. (MGNI) was originally founded as Rubicon Project in 2007 by four people (Duc Chau, Frank Addante, Julie Mattern, and Craig Roah) who had previously worked at the online advertising company L90. The company quickly attracted funding, raising $42 million before the end of 2009. Rubicon Project transformed into Magnite after a 2020 merger […]
Buy Gold & Silver with Your IRA/401(k) Using this IRS Loophole
Rollover your 401K to a precious metals IRA and protect yourself & family from inflation. From the #1 gold IRA Company, This free gold & silver IRA guide will show you how you can roll over your IRA or 401(k) into precious metals. Tax free & penalty-free into an IRA holding using a loophole the IRS doesn't want you to know!
Is Live Nation Stock a Buy?
Live Nation Entertainment, Inc (NYSE:LYV) is a global live entertainment conglomerate that formed from the merger of Live Nation and Ticketmaster in 2010. The company was on a steady growth trajectory until the pandemic shut down live events in 2020. With the economy reopening, Live Nation Entertainment is quickly growing into a $20 billion juggernaut. […]
A Rare Opportunity to Turn $1,000 into $461,800
On August 30, 2019, a small firm won a contract from the Pentagon to build a strange new weapon. The Joint Chiefs of Staff calls this new weapon "Unstoppable." This under-the-radar company is not yet a household name.
Our research proves that anyone who gets in now could turn $1,000 into $461,800 >>>
View this email online if it doesn't display correctly. This newsletter is not financial advice. Please read our Disclaimer.
To unsubscribe from Financhill, click here.
PO Box 126
Catasauqua, PA 18032
Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.
The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.
The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The Financhill.com educational training program and software services are provided to improve financial understanding.
The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.
Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.
No comments:
Post a Comment